Effect of testosterone on post-myocardial infarction remodeling and function.

BACKGROUND Men and women are differently affected by coronary artery disease, suggesting an important role of sex steroids. Moreover, testosterone (T) treatment is increasingly used in elderly males. Therefore, we examined effects of chronic anabolic T administration on left ventricular (LV) remodeling after myocardial infarction (MI). METHODS Adult male rats were treated with intramuscular placebo, testosterone undecanoate (T), or were orchiectomized. After 2 weeks, animals underwent sham-operation (sham) or left coronary artery ligation. Left ventricular remodeling and function was assessed by serial magnetic resonance imaging (MRI) at weeks 2 and 8 and hemodynamic investigation at week 8. RESULTS In sham operated animals T administration increased serum T levels and led to cardiac hypertrophy, but not to an upregulation of ANP mRNA. The alpha/beta-MHC ratio was significantly higher after T treatment due to an increase in alpha-MHC. As a potential mechanism for this "physiologic" form of hypertrophy, IGF-1 mRNA expression was significantly increased in T treated animals. After coronary artery ligation, infarct size and mortality were similar among the groups. Left ventricular hypertrophy was enhanced by T treatment. However, in vivo LV end-diastolic pressure and wall stress were decreased by T, whereas other hemodynamic parameters (mean arterial pressure, cardiac output, etc.) remained unchanged. CONCLUSION Chronic anabolic T treatment led to a specific "physiologic" pattern of myocardial hypertrophy with a significant increase in LV weight, but without differences in ANP and with an upregulation in alpha/beta-MHC, possibly mediated by IGF-1. Testosterone treatment had no detrimental effects following MI. Reduced wall stress and LVEDP may even improve long-term outcome.

[1]  P. Leung,et al.  ANDROGEN DEPENDENT EXPRESSION OF AT1 RECEPTOR AND ITS REGULATION OF ANION SECRETION IN RAT EPIDIDYMIS , 2002, Cell biology international.

[2]  G. Ertl,et al.  Effect of endurance training early or late after coronary artery occlusion on left ventricular remodeling, hemodynamics, and survival in rats with chronic transmural myocardial infarction. , 1994, Circulation.

[3]  A. Dobs,et al.  Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. , 2001, The Journal of clinical endocrinology and metabolism.

[4]  D. Mann Recent Insights into the Role of Tumor Necrosis Factor in the Failing Heart , 2001, Heart Failure Reviews.

[5]  R. Rockhold Cardiovascular toxicity of anabolic steroids. , 1993, Annual review of pharmacology and toxicology.

[6]  R. Melchert,et al.  The effect of anabolic-androgenic steroids on primary myocardial cell cultures. , 1992, Medicine and science in sports and exercise.

[7]  A Haase,et al.  In vivo assessment of cardiac remodeling after myocardial infarction in rats by cine-magnetic resonance imaging. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[8]  W. Bremner,et al.  Androgens in men--uses and abuses. , 1996, The New England journal of medicine.

[9]  J. Ayanian Increased Mortality among Middle-Aged Women after Myocardial Infarction: Searching for Mechanisms and Solutions , 2001, Annals of Internal Medicine.

[10]  R. Wolfe,et al.  Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. , 1995, The American journal of physiology.

[11]  J. Pell,et al.  Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. , 2001, Journal of the American College of Cardiology.

[12]  S. Neubauer,et al.  Evidence against a role of physiological concentrations of estrogen in post-myocardial infarction remodeling. , 1999, Journal of the American College of Cardiology.

[13]  H. Krumholz,et al.  Sex Differences in 2-Year Mortality after Hospital Discharge for Myocardial Infarction , 2001, Annals of Internal Medicine.

[14]  P. Gennis,et al.  The cardiac toxicity of anabolic steroids. , 1998, Progress in cardiovascular diseases.

[15]  A. Dobs,et al.  Hypogonadism and androgen replacement therapy in elderly men. , 2001, The American journal of medicine.

[16]  R. Kloner,et al.  Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light , 1994, Basic Research in Cardiology.

[17]  F. Weidemann,et al.  Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. , 1998, Cardiovascular research.

[18]  Y. Kihara,et al.  Modulation of in vivo cardiac hypertrophy with insulin-like growth factor-1 and angiotensin-converting enzyme inhibitor: relationship between change in myosin isoform and progression of left ventricular dysfunction. , 2000, Journal of the American College of Cardiology.

[19]  E. Barrett-Connor,et al.  Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. , 1988, Circulation.

[20]  R. Medzhitov,et al.  Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. , 1999, The Journal of clinical investigation.

[21]  E. Lucchinetti,et al.  Anabolic‐androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes , 2001, Journal of cellular physiology.

[22]  D. Grobbee,et al.  Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men Society , 2003 .

[23]  Mark A Sussman,et al.  Cardiac-Specific IGF-1 Expression Attenuates Dilated Cardiomyopathy in Tropomodulin-Overexpressing Transgenic Mice , 2002, Circulation research.

[24]  P. Douglas,et al.  Gender Differences in Postinfarction Left Ventricular Remodeling , 1999, Cardiology.

[25]  P. V. van Kesteren,et al.  Mortality and morbidity in transsexual subjects treated with cross‐sex hormones , 1997, Clinical endocrinology.

[26]  N. Mauras,et al.  Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. , 1998, The Journal of clinical endocrinology and metabolism.

[27]  C. Christiansen,et al.  The relationship of natural androgens to coronary heart disease in males: a review. , 1996, Atherosclerosis.

[28]  D. Ganten,et al.  Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. , 1990, Circulation research.

[29]  M. Karkkainen,et al.  Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells , 1999, Molecular and Cellular Endocrinology.

[30]  D. Padgett,et al.  Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol , 1998, Journal of Neuroimmunology.

[31]  H. Mcgill,et al.  The heart is a target organ for androgen. , 1980, Science.

[32]  J. Gwathmey,et al.  Androgen receptors mediate hypertrophy in cardiac myocytes. , 1998, Circulation.

[33]  G. Norton,et al.  Novel attributes of an androgenic steroid-mediated increase in cardiac end diastolic stiffness in rats , 1998 .

[34]  K. Desai,et al.  Androgen ablation results in differential regulation of transforming growth factor-beta isoforms in rat male accessory sex organs and epididymis. , 2000, Journal of molecular endocrinology.

[35]  J. Scheuer,et al.  The Effects of Gonadectomy on Left Ventricular Function and Cardiac Contractile Proteins in Male and Female Rats , 1984, Circulation research.

[36]  P. Sugden,et al.  Stimulation of cardiac protein synthesis by insulin-like growth factors. , 1992, The Biochemical journal.